XML 28 R11.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Note 3 - Earnings Per Common Share | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Earnings Per Share [Text Block] | Note 3– Earnings per Common Share FASB ASC 260-10-45, “Earnings Per Share”, addresses whether instruments granted in share-based payment transactions are participating securities prior to vesting and, therefore, need to be included in the earnings allocation in computing earnings per share (“EPS”). The restricted stock awards granted by the Company contain non-forfeitable rights to dividends and therefore are considered participating securities. The two-class method for calculating basic EPS excludes dividends paid to participating securities and any undistributed earnings attributable to participating securities. Earnings per common share have been computed based on the following:
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (in thousands, except per share amounts) |
Net income available to common stockholders |  | $ | 67,757 |  |  | $ | 80,967 |  |  | $ | 119,174 |
Earnings allocated to participating securities |  |  | (187 | ) |  |  | (216 | ) |  |  | (287 | )
Income attributable to common stock |  | $ | 67,570 |  |  | $ | 80,751 |  |  | $ | 118,887 |
Weighted average common shares outstanding, including participating securities |  |  | 38,376 |  |  |  | 38,913 |  |  |  | 39,355 |
Weighted average participating securities |  |  | (106 | ) |  |  | (104 | ) |  |  | (95 | )
Weighted average common shares outstanding |  |  | 38,270 |  |  |  | 38,809 |  |  |  | 39,260 |
Incremental shares from assumed conversions of options, deferred stock units, performance units and restricted stock |  |  | 211 |  |  |  | 153 |  |  |  | 216 |
Weighted average common and equivalent shares outstanding |  |  | 38,481 |  |  |  | 38,962 |  |  |  | 39,476 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1.77 |  |  | $ | 2.08 |  |  | $ | 3.03 |
Diluted |  |  | 1.76 |  |  |  | 2.07 |  |  |  | 3.01 |
There were no antidilutive common share equivalents as of December 31, 2024, 2023 and 2022.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration